These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 19016371)

  • 1. Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.
    Schermann CM; Fischer G; Witt V; Kurz M; Potschger U; Fritsch G
    Cytotherapy; 2008; 10(8):834-41. PubMed ID: 19016371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of virus-specific T lymphocytes: practicability of detection of HCMV-specific T lymphocytes in whole blood in patients after stem cell transplantation.
    Buxbaum S; Kraus FB; Hahn A; Beck O; Kabartas B; Doerr HW; Ludwig B
    J Immunol Methods; 2006 Apr; 311(1-2):164-73. PubMed ID: 16530782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
    Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G
    Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus specific CD8(+) T lymphocytes display interferon-gamma secretion impairment in kidney transplant recipients with pp65 antigenemia.
    Yang R; Xia T; Xu G; Li Z; Ying Z; Xu X
    Transplant Proc; 2008 Dec; 40(10):3500-4. PubMed ID: 19100424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection.
    Lilleri D; Fornara C; Revello MG; Gerna G
    J Infect Dis; 2008 Aug; 198(4):536-43. PubMed ID: 18590456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS; Mackinnon S
    Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus.
    Lilleri D; Fornara C; Furione M; Zavattoni M; Revello MG; Gerna G
    J Infect Dis; 2007 Apr; 195(7):1062-70. PubMed ID: 17330798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
    Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
    J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.
    Eid AJ; Brown RA; Hogan WJ; Lahr BD; Eckel-Passow JE; Litzow MR; Razonable RR
    Transpl Infect Dis; 2009 Dec; 11(6):519-28. PubMed ID: 19744286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.
    Ludwig B; Kraus FB; Kipp M; Preiser W; Schwerdtfeger R; Doerr HW; Buxbaum S
    J Clin Virol; 2006 Feb; 35(2):160-6. PubMed ID: 16112610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
    La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
    Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells.
    Lozza L; Lilleri D; Percivalle E; Fornara C; Comolli G; Revello MG; Gerna G
    Eur J Immunol; 2005 Jun; 35(6):1795-804. PubMed ID: 15902686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T; Dunne J; Crowley B
    J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.
    Cho HI; Han H; Kim CC; Kim TG
    J Immunother; 2001; 24(3):242-9. PubMed ID: 11394502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.
    Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; Garcia-Noblejas A; Clari MA; Chilet M; López J; Hernández-Boluda JC; Remigia MJ; Navarro D
    J Med Virol; 2010 Jul; 82(7):1208-15. PubMed ID: 20513086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.
    Lacey SF; Diamond DJ; Zaia JA
    Biol Blood Marrow Transplant; 2004 Jul; 10(7):433-47. PubMed ID: 15205665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the HLA haplotype and the TCR-Vbeta repertoire of anti-hCMV specific memory T-cells in immunocompetent healthy adults.
    Rodriguez-Caballero A; Garcia-Montero AC; Almeida J; Balanzategui A; Munoz-Criado S; Orfao A
    Cytometry B Clin Cytom; 2007 Sep; 72(5):371-9. PubMed ID: 17328033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.